Key Dates
April 4, 2024
Related Announcements
- September 10, 2021 - AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional. See NOFO PAS-21-270.
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to add additional application receipt date in 2024, to the list of application due dates, for PAS-21-270., AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
Key Dates
Currently reads:
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
Not Applicable | Not Applicable | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
Not Applicable | Not Applicable | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
Not Applicable | Not Applicable | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
Not Applicable | Not Applicable | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
Not Applicable | Not Applicable | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
Not Applicable | Not Applicable | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
Not Applicable | Not Applicable | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
Not Applicable | Not Applicable | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
Not Applicable | Not Applicable | September 07, 2024 * | November 2024 | January 2025 | April 2025 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
September 08, 2024
Modified to read (in Bold italics):
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
Not Applicable | Not Applicable | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
Not Applicable | Not Applicable | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
Not Applicable | Not Applicable | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
Not Applicable | Not Applicable | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
Not Applicable | Not Applicable | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
Not Applicable | Not Applicable | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
Not Applicable | Not Applicable | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
Not Applicable | Not Applicable | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
Not Applicable | Not Applicable | September 07, 2024 * | November 2024 | January 2025 | April 2025 |
| Not Applicable | Not Applicable | January 7, 2025 | March 2025 | May 2025 | July 2025 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
January 8, 2025
All other aspects of the NOFO remain the same.
Inquiries
Please direct all inquiries to:
Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1923
Email: jenkinsri@mail.nih.gov
Yu (Woody) Lin, MD, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1318
Email: ylin1@nida.nih.gov
Raul N. Mandler, MD
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-2541
Email: mandlerr@mail.nih.gov
and Human Services (HHS)
